Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells

Clinical Cancer Research

Volumn 11, Issue 6, 2005, Pages 2427-2435

  Shimauchi, Takatoshi ^a   Imai, Satoshi ^a   Hino, Ryosuke ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 28; MONOCLONAL ANTIBODY CD3; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOGENESIS; SKIN METASTASIS; T CELL LEUKEMIA; T LYMPHOCYTE; TH2 CELL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TH2 CELLS; THYMUS GLAND;

EID: 16844376372     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0491     Document Type: Article

References (40)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-9.
3. Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Physicians 1999;111:563-72.
4. Edlich RP, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000;18:109-19.
5. Shimoyama M; Members of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428-37.
6. Setoyama M, Katahira Y, Kanzaki T. Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought. J Dermatol 1999;26:785-90.
7. Ferenczi K, Fuhlbrigge RC, Piakus JL, Pinkus GS, Kupper TS. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002;119:1405-10.
8. Kakinuma T, Sugaya M, Nakamura K, et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003;48:23-30.
9. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000;115:640-6.
10. Hirata H, Arima M, Cheng G, et al. Production of TARC and MDC by naïve T cells in asthmatic patients. J Clin Immunol 2003;23:34-45.
11. Mori N, Ueda A, Ikeda S, et al. Human T-cell leukemia virus type I Tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-κB sites. Cancer Res 2000;60:4939-45.
12. Tanaka Y, Mine S, Figdor CG, et al. Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Blood 1998;91:3909-19.
13. Sharma V, Lorey SL. Autocrine role of macrophage inflammatory protein-1β in human T-cell lymphotrophic virus type-I tax-transfected Jurkat T-cells. Biochem Biophys Res Commun 2001;287:910-3.
14. Ruckes T, Saul D, Snick JV, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 2001;98:1150-9.
15. Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002;99:1505-11.
16. Ishida T, Utsunomia A, Iida S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003;9:3625-34.
17. Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 2000;95:30-8.
18. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272:15036-47.
19. Imai T, Chantry D, Raport CJ, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273:1764-8.
20. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-3.
21. Cole KE, Strick CA, Paradis TJ, et al. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998;187:2009-21.
22. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-9.
23. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a signal mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
24. Iwatsuki K, Harada H, Motoki Y, Kaneko F, Jin F, Takigawa M. Diversity of immunobiological functions of T-cell lines established from patients with adult T-cell leukaemia. Br J Dermatol 1995;133:861-7.
25. Yamada Y, Ohmoto Y, Hata T, et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma 1996;21:443-7.
26. + bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage derived chemokine. Int Immunol 1999;11:81-8.
27. Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998;161:5027-38.
28. + regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
29. + regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 2004;126:81-4.
30. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999;94:845-52.
31. Inngjerdingen M, Damaj B, Maghazachi AA. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 2000;164:4048-54.
32. Sekiya T, Miyamasu M, Imanishi M, et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000;165:2205-13.
33. Vermeer MH, Dukers DF, Berge TRL, et al. Differential expression of thymus and activation regulated chemokines and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease. Mod Pathol 2002;15:838-44.
34. Peh SC, Kim LH, Poppema S. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 2001;25:925-9.
35. Berg VDA, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Stemberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 1999;154:1685-91.
36. Albanesi C, Scarponi C, Sebastiani S, et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin disease. J Leukoc Biol 2001;70:617-23.
37. Tsuda T, Tohyama M, Yamasaki K, et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 2003;31:37-42.
38. Vowels BR, Lessin SR, Cassin M, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994;103:669-73.
39. Yagi H, Tokura Y, Furukawa F, Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ. J Invest Dermatol 1996;107:827-32.
40. Tokura Y, Heald PW, Yan SL, Edelson RL. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococal toxins. J Invest Dermatol 1992;98:33-7.